Cooperative Assembly and Misfolding of CFTR Domains In Vivo
Open accessAbstract
The cystic fibrosis transmembrane conductance regulator (CFTR) architecture consists of two membrane spanning domains (MSD1 and -2), two nucleotide binding domains (NBD1 and -2), and a regulatory (R) domain. Several point mutations lead to the channel misprocessing, with limited structural perturbation of the mutant domain. To gain more insight into the basis of CFTR folding defect, the contribution of domain-wise and cooperative domain folding was assessed by determining 1) the minimal domain combination that is recognized as native and can efficiently escape the endoplasmic reticulum (ER) retention and 2) the impact of mutation on the conformational coupling among domains. One-, two-, three-, and most of the four-domain assemblies were retained at the ER. Solubilization mutations, however, rescued the NBD1 processing defect conceivably by thermodynamic stabilization. The smallest folding unit that traversed the secretory pathway was composed of MSD1-NBD1-R-MSD2 as a linear or split polypeptide. Cystic fibrosis-causing missense mutations in the MSD1, NBD1, MSD2, and NBD2 caused conformational defect in multiple domains. We propose that cooperative posttranslational folding is required for domain stabilization and provides a plausible explanation for the global misfolding caused by point mutations dispersed along the full-length CFTR.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
F508del impairs NBD1 stability and the coupled or cooperative domain folding of CFTR.
“F508del impairs the NBD1 stability and the coupled or cooperative domain folding of the channel (9–11).”
From Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination (2020) · cites this paper as [11]
The cooperative F508del-CFTR domain misfolding can be robustly reversed by allosteric pharmacochaperones that synergistically stabilize NBD1 unfolding intermediates and the MSD1 by type III (VX-445) and type I (VX-661) correctors, respectively.
“These observations illustrate that the cooperative F508del-CFTR domain misfolding (10, 11, 51) can be robustly reversed by allosteric pharmacochaperones that synergistically stabilize NBD1 unfolding intermediates and the MSD1 by type III (VX-445) and type I (VX-661) correctors, respectively.”
From Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination (2020) · cites this paper as [11]
Cited by
Sorted by citations
Veit, G., Roldan, A., Hancock, M. A., Da Fonte, D. F., Xu, H., Hussein, M., Frenkiel, S., Matouk, E., Velkov, T., & Lukacs, G. L. (2020) · JCI Insight · doi:10.1172/jci.insight.139983 · Cited by 250 · see citing works
- Authors
- Du, K., & Lukacs, G. L.
- Affiliations
- McGill University (CA)
- Department of Physiology, McGill University, Montreal, Quebec, Canada H3G 1Y6
- ORCID
- Du, Kai
- Venue
- Molecular Biology of the Cell
- Published
- 2009-04
- Volume
- 20
- Issue
- 7
- Pages
- 1903-1915
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- PMC
- PMC2663924
- OpenAlex
- W2049696186
- Cited by
- 147
- References
- 0
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 7 · 2021: 11 · 2020: 9 · 2019: 9 · 2018: 11 · 2017: 11 · 2016: 9 · 2015: 9 · 2014: 12 · 2013: 6 · 2012: 17
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Molecular Biology of the Cell (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cystic Fibrosis Foundation
- Cystic Fibrosis Foundation Therapeutics
- National Institutes of Health
- Canadian Institutes of Health Research
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- CFTR, cystic fibrosis, protein misfolding, cooperative folding, nucleotide-binding domain, transmembrane domain, endoplasmic reticulum retention, conformational coupling, missense mutations, protein secretion
- MeSH terms
- Animals, Biological Assay, Cell Line, Cytosol, Kinetics, Protein Processing, Post-Translational, Point Mutation, Protein Structure, Tertiary, Protein Folding, Cystic Fibrosis Transmembrane Conductance Regulator, Mutation, Missense, Intracellular Space, Mutant Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review